Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial

Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial

BACKGROUND: Early detection and treatment of asymptomatic men with advanced and high-risk prostate cancer (PCa) may improve survival rates. OBJECTIVE: To determine outcomes for men diagnosed with advanced PCa following prostate-specific antigen (PSA) testing who were excluded from the ProtecT random...

Full description

Bibliographic Details
Main Authors: Johnston, T, Shaw, G, Lamb, A, Parashar, D, Greenberg, D, Xiong, T, Edwards, A, Gnanapragasam, V, Holding, P, Herbert, P, Davis, M, Mizielinsk, E, Lane, J, Oxley, J, Robinson, M, Mason, M, Staffurth, J, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Prescott, S, Paul, A, Powell, P, Rosario, D, Rowe, E, Donovan, J, Hamdy, F, Neal, D, ProtecT study group
Format: Journal article
Language:English
Published: Elsevier 2016

Similar Items